{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:10:41Z","timestamp":1748491841748,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04837-y","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:06:01Z","timestamp":1748455561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation therapy and related outcomes among Asian patients after bioprosthetic valve replacement"],"prefix":"10.1186","volume":"25","author":[{"given":"Tang-Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Hsin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Chien-Chia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Chih","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Chang","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao-Hsien","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"12","key":"4837_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","volume":"18","author":"S Coffey","year":"2021","unstructured":"Coffey S, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853\u201364.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"4837_CR2","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013227.","journal-title":"Circulation"},{"issue":"5","key":"4837_CR3","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jtcvs.2013.12.042","volume":"148","author":"RS McClure","year":"2014","unstructured":"McClure RS, et al. Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position: a propensity-matched analysis. J Thorac Cardiovasc Surg. 2014;148(5):1931\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"4837_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","volume":"121","author":"PS Wells","year":"1994","unstructured":"Wells PS, et al. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121(9):676\u201383.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4837_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","volume":"50","author":"AY Shen","year":"2007","unstructured":"Shen AY, et al. Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50(4):309\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4837_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1253\/circj.CJ-14-1057","volume":"79","author":"E Kodani","year":"2015","unstructured":"Kodani E, et al. Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation - subanalysis of the J-RHYTHM Registry. Circ J. 2015;79(2):325\u201330.","journal-title":"Circ J"},{"issue":"2","key":"4837_CR7","doi-asserted-by":"publisher","first-page":"e2146026","DOI":"10.1001\/jamanetworkopen.2021.46026","volume":"5","author":"J-T Huang","year":"2022","unstructured":"Huang J-T, et al. Analysis of Anticoagulation Therapy and Anticoagulation-Related Outcomes Among Asian Patients After Mechanical Valve Replacement. JAMA Netw Open. 2022;5(2):e2146026\u2013e2146026.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"4837_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/pds.4713","volume":"28","author":"SC Shao","year":"2019","unstructured":"Shao SC, et al. The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593\u2013600.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"4837_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bj.2017.08.002","volume":"40","author":"MS Tsai","year":"2017","unstructured":"Tsai MS, et al. Chang Gung Research Database: A multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263\u20139.","journal-title":"Biomed J"},{"issue":"1","key":"4837_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.11.036","volume":"232","author":"CH Chang","year":"2014","unstructured":"Chang CH, et al. Continuation of statin therapy and a decreased risk of atrial fibrillation\/flutter in patients with and without chronic kidney disease. Atherosclerosis. 2014;232(1):224\u201330.","journal-title":"Atherosclerosis"},{"key":"4837_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijcard.2015.10.091","volume":"203","author":"YS Lin","year":"2016","unstructured":"Lin YS, et al. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study. Int J Cardiol. 2016;203:204\u201311.","journal-title":"Int J Cardiol"},{"issue":"13","key":"4837_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","volume":"369","author":"JW Eikelboom","year":"2013","unstructured":"Eikelboom JW, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206\u201314.","journal-title":"N Engl J Med"},{"issue":"3","key":"4837_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40256-020-00449-3","volume":"21","author":"AR Duraes","year":"2021","unstructured":"Duraes AR, et al. Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial-The RIWA study. Am J Cardiovasc Drugs. 2021;21(3):363\u201371.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"4837_CR14","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/CIRCULATIONAHA.108.778886","volume":"119","author":"P Pibarot","year":"2009","unstructured":"Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119(7):1034\u201348.","journal-title":"Circulation"},{"issue":"6","key":"4837_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jacc.2015.11.046","volume":"67","author":"MJ Mack","year":"2016","unstructured":"Mack MJ, Douglas PS, Holmes DR. Shedding More Light on Valve Thrombosis After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016;67(6):656\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4837_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejcts.2007.12.019","volume":"33","author":"A Colli","year":"2008","unstructured":"Colli A, et al. Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results. Eur J Cardiothorac Surg. 2008;33(4):531\u20136.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"4837_CR17","first-page":"78","volume":"21","author":"JM Brennan","year":"2012","unstructured":"Brennan JM, et al. Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER. J Heart Valve Dis. 2012;21(1):78\u201387.","journal-title":"J Heart Valve Dis"},{"issue":"5","key":"4837_CR18","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","volume":"25","author":"M Heras","year":"1995","unstructured":"Heras M, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25(5):1111\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"4837_CR19","doi-asserted-by":"publisher","first-page":"755009","DOI":"10.3389\/fphar.2022.755009","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, et al. Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022;13:755009.","journal-title":"Front Pharmacol"},{"issue":"13","key":"4837_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.287.13.1690","volume":"287","author":"MK Higashi","year":"2002","unstructured":"Higashi MK, et al. Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy. JAMA. 2002;287(13):1690\u20138.","journal-title":"JAMA"},{"issue":"4","key":"4837_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1182\/blood-2015-02-627042","volume":"126","author":"NA Limdi","year":"2015","unstructured":"Limdi NA, et al. Race influences warfarin dose changes associated with genetic factors. Blood. 2015;126(4):539\u201345.","journal-title":"Blood"},{"issue":"9","key":"4837_CR22","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.amjcard.2017.07.050","volume":"120","author":"T Liu","year":"2017","unstructured":"Liu T, et al. Meta-Analysis of Efficacy and Safety of Low-Intensity Warfarin Therapy for East Asian Patients With Nonvalvular Atrial Fibrillation. Am J Cardiol. 2017;120(9):1562\u20137.","journal-title":"Am J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04837-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04837-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04837-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:06:01Z","timestamp":1748455561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04837-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4837"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04837-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}